Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

State of the States

A roundup of regulatory activity around the country
Summer 2022

Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workface amid COVID-19 and beyond.
Winter 2021/2022

State of the States

Sandy Shtab, Healthesystems AVP of Advocacy and Compliance, comments on regulatory activity across the country.
Winter 2021/2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Then and Now: 8 Reflections from 15 Years of RxInformer

In celebration of the 15 year anniversary of RxInformer, the editorial staff looked back at past issues to understand what has changed – and what hasn’t.
May 2025

WCRI Reports on the Impact of Marijuana Laws on Workers’ Comp Benefits

While recreational marijuana laws may be tied to increases in claim frequency, medical payments and prescriptions decreased, including those for opioids.
May 2025

State of the Nation with Sandy Shtab

Healthesystems VP of State & Industry Affairs comments on recent federal activity that creates potential impacts for workers’ comp.
May 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

FDA Addresses Manufacturing Disruptions

Will disruptions in manufacturing result in drug shortages?
Mar 2020

NSAID Use and COVID-19

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
Mar 2020

COVID-19 and Clinical Trials

COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.
Mar 2020
1 17 18 19 20 21 28

Whitepapers

lockmap-markermagnifiercrossmenucross-circle